Tarsus Pharmaceuticals Inc. – Underwriting Agreements

NASDAQ: TARS
Share price (8/10/26): $67.76
Market cap (8/10/26): $2.974 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from 8-K 46 pages Tarsus Pharmaceuticals, Inc. (A Delaware Corporation) 2,808,988 Shares of Common Stock Underwriting Agreement

from 8-K 58 pages Tarsus Pharmaceuticals, Inc. (A Delaware Corporation) 2,812,500 Shares of Common Stock Pre-Funded Warrants to Purchase 312,500 Shares of Common Stock Underwriting Agreement

from 8-K 45 pages Tarsus Pharmaceuticals, Inc. (A Delaware Corporation) 5,714,285 Shares of Common Stock Underwriting Agreement

from 8-K 44 pages Tarsus Pharmaceuticals, Inc. (A Delaware Corporation) 5,600,000 Shares of Common Stock Underwriting Agreement

from S-3 40 pages Open Market Sale Agreementsm

from SC 13G/A 1 page Joint Filing Statement Pursuant to Rule 13d-1

from SC 13G 1 page Joint Filing Statement Pursuant to Rule 13d-1

from S-1/A 48 pages Tarsus Pharmaceuticals, Inc. (A Delaware Corporation) [●] Shares of Common Stock Underwriting Agreement